Search Results
Novo Nordisk highlights heart benefits from Phase 3 trial of weight loss drug #NVOStock #Wegovy
Wegovy’s Longest Clinical Trial Results Weight Loss, Side Effects, and Heart Protection l HIT News
Obesity Drug "Tricks" Your Body Into Burning Fat? Exercise Mimetics Science
NIH Obesity Research Task Force Symposium: Obesity and Heart Disease Webinar
NIH Obesity Research Task Force Symposium: Medications to Treat Obesity: Past, Present, and Future
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
Lowering the Cardiovascular Burden With Novel Weight Loss Therapies: An Expert Digest From ESC
Obesity Management Medications: Role in Treatment and Support | IFSO 2024
ADA Clinical Trial Talks: Oral Semaglutide for Treatment of Obesity and Type 2 Diabetes
The Biggest Breakthrough in Medicine in Decades
S4-E9.4 - Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Fr
May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting